Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -112458% | $ -56.23M | $ 50K |
3/31/2025 | -83046% | $ -41.52M | $ 50K |
12/31/2024 | -304535.71% | $ -42.63M | $ 14K |
9/30/2024 | -99557.14% | $ -41.81M | $ 42K |
6/30/2024 | -44771.76% | $ -38.06M | $ 85K |
3/31/2024 | -26413.74% | $ -34.6M | $ 131K |
12/31/2023 | -19360% | $ -30.01M | $ 155K |
9/30/2023 | -12657.14% | $ -28.35M | $ 224K |
6/30/2023 | -9773.12% | $ -27.27M | $ 279K |
3/31/2023 | -11122.09% | $ -27.69M | $ 249K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for INMUNE BIO INC is calculated as follows: Op. Inc. [ $ -11.35M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.26K |
---|---|
min | -71.54% |
max | 83.41% |
average | 9.03% |
median | 8.77% |
std | 23.72% |